Pure Biologics (WAR:PUR) FCF Yield % : -72.25 (As of Jun. 05, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Pure Biologics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Pure Biologics's Trailing 12-Month Free Cash Flow is zł-16.06 Mil, and Market Cap is zł22.23 Mil. Therefore, Pure Biologics's FCF Yield % for today is -72.25%.

The historical rank and industry rank for Pure Biologics's FCF Yield % or its related term are showing as below:

WAR:PUR' s FCF Yield % Range Over the Past 10 Years
Min: -124.83 Med: -9.76 Max: 10.89
Current: -72.25

During the past 8 years, the highest FCF Yield % of Pure Biologics was 10.89%. The lowest was -124.83%. And the median was -9.76%.

WAR:PUR's FCF Yield % is ranked worse than
80.55% of 1553 companies
in the Biotechnology industry
Industry Median: -14.22 vs WAR:PUR: -72.25

Pure Biologics's FCF Margin % for the quarter that ended in Mar. 2024 was 75,200.00%.

Pure Biologics FCF Yield % Historical Data

The historical data trend for Pure Biologics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pure Biologics FCF Yield % Chart

Pure Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

11.77

-1.04

-14.09

-44.65

-55.72

Pure Biologics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-37.05	-59.80	-60.78	-33.12	33.52

Competitive Comparison of Pure Biologics's FCF Yield %

For the Biotechnology subindustry, Pure Biologics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pure Biologics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pure Biologics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Pure Biologics's FCF Yield % falls into.

Pure Biologics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Pure Biologics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-23.438	/	42.0635184
	=	-55.72%

Pure Biologics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	2.256	*	4	/	26.9219829
	=	33.52%

Pure Biologics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Pure Biologics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Pure Biologics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pure Biologics (WAR:PUR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pure Biologics SA (WAR:PUR) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

PQB:Germany

Address

ul. Dunska 11, Wroclaw, POL, 54-427

Website

http://www.purebiologics.pl

Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.

Pure Biologics (WAR:PUR) Headlines

No Headlines